{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Macrophages",
      "NF-\u03baB",
      "Neutrophils",
      "OncomiR",
      "Tumor suppressor",
      "microRNA"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "30878527",
  "DateCompleted": {
    "Year": "2020",
    "Month": "02",
    "Day": "14"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "06",
    "Day": "01"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2019",
        "Month": "03",
        "Day": "13"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.canlet.2019.02.051",
      "S0304-3835(19)30151-X"
    ],
    "Journal": {
      "ISSN": "1872-7980",
      "JournalIssue": {
        "Volume": "451",
        "PubDate": {
          "Year": "2019",
          "Month": "Jun",
          "Day": "01"
        }
      },
      "Title": "Cancer letters",
      "ISOAbbreviation": "Cancer Lett"
    },
    "ArticleTitle": "miRNA-223 at the crossroads of inflammation and cancer.",
    "Pagination": {
      "StartPage": "136",
      "EndPage": "141",
      "MedlinePgn": "136-141"
    },
    "Abstract": {
      "AbstractText": [
        "miR-223 is an evolutionarily conserved anti-inflammatory microRNA primarily expressed in myeloid cells. miR-223 post-transcriptionally regulates many genes essential in inflammation, cell proliferation, and invasion. Recent studies show that miR-223 is either endogenously expressed or transferred in exosomes or extracellular vesicles to non-phagocytic cells including cancer cells, where it exerts biological functions. In cancerous cells, miR-223 acts either as an oncomiR promoting tumors or as a tumor suppressor in a context-dependent manner. Taken together, miR-223 can regulate tumorigenesis at multiple levels, including by suppressing the inflammatory tumor microenvironment and modulating malignancy of cancer cells."
      ],
      "CopyrightInformation": "Copyright \u00a9 2019. Published by Elsevier B.V."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biological Sciences, Purdue University, West Lafayette, IN, 47907, USA."
          }
        ],
        "LastName": "Jeffries",
        "ForeName": "Jacob",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biological Sciences, Purdue University, West Lafayette, IN, 47907, USA."
          }
        ],
        "LastName": "Zhou",
        "ForeName": "Wenqing",
        "Initials": "W"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biological Sciences, Purdue University, West Lafayette, IN, 47907, USA."
          }
        ],
        "LastName": "Hsu",
        "ForeName": "Alan Y",
        "Initials": "AY"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Biological Sciences, Purdue University, West Lafayette, IN, 47907, USA; Purdue Institute for Inflammation, Immunology, and Infectious Disease, Purdue University, West Lafayette, IN, 47907, USA; Purdue Center for Cancer Research, Purdue University, West Lafayette, IN, 47907, USA. Electronic address: deng67@purdue.edu."
          }
        ],
        "LastName": "Deng",
        "ForeName": "Qing",
        "Initials": "Q"
      }
    ],
    "GrantList": [
      {
        "GrantID": "R35 GM119787",
        "Acronym": "GM",
        "Agency": "NIGMS NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Ireland",
    "MedlineTA": "Cancer Lett",
    "NlmUniqueID": "7600053",
    "ISSNLinking": "0304-3835"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "MIRN223 microRNA, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "MicroRNAs"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Carcinogenesis"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Exosomes"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Extracellular Vesicles"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "physiopathology"
      ],
      "DescriptorName": "Inflammation"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "MicroRNAs"
    },
    {
      "QualifierName": [
        "metabolism",
        "physiopathology"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Tumor Microenvironment"
    }
  ],
  "CoiStatement": "Competing interests: The authors declare no competing financial interests."
}